Tempus AI, Inc. (TEM) 주식 분석

회사 개요

Tempus AI, Inc. is a healthcare technology company operating in the United States that provides the Tempus platform, a closed-loop, full-stack solution integrating clinician desktops with laboratory diagnostic capabilities, analytics, and a repository of multimodal data. The company functions within the Healthcare sector, specifically the Health Information Services industry, positioning itself at the intersection of medical data science and operational infrastructure. Tempus currently maintains a market capitalization of $8.52B and employs approximately 3,800 individuals, while reporting a trailing twelve-month revenue of $1.27B. These valuation and revenue figures indicate that the market assigns a significant premium to the company's proprietary technology and data assets, reflecting high expectations for its ability to scale data-driven solutions across the medical ecosystem.

재무 건전성

The company reported a revenue of $1.27B and an EBITDA of $-171,512,992 over the trailing twelve months, yet it posted a net income loss of $-245,028,000. The substantial gap between the positive revenue and the negative net income reveals a cost structure where non-operating expenses or significant interest costs are eroding profitability before the bottom line is reached. Free cash flow stands at $-112,498,872, which indicates that the company is currently consuming cash reserves to fund operations and growth initiatives rather than generating excess liquidity for shareholders. On a margin basis, the gross margin is 62.7%, suggesting efficient core production or service delivery, while the operating margin of -16.7% and profit margin of -19.3% highlight that high fixed costs or scaling expenses are suppressing overall profitability. The balance sheet shows a cash position of $755.00M against total debt of $1.33B, resulting in a debt-to-equity ratio of 270.11, which characterizes the firm as a highly leveraged entity relying heavily on equity or cash to support its obligations. Despite the high leverage, the current ratio of 3.13 suggests strong short-term liquidity, as current assets are more than three times current liabilities, providing a buffer for immediate financial needs. Finally, the return on equity is -89.5% and return on assets is -9.7%, metrics that reveal that management has not yet achieved positive returns on the capital deployed, a common characteristic for high-growth technology firms still in the investment phase.

밸류에이션 평가

Valuation metrics for Tempus present a complex picture given its lack of consistent earnings, with a trailing P/E ratio listed as N/A and a forward P/E of -760.61. The negative forward P/E implies that analysts do not expect normalized earnings in the near term, which creates a wide divergence between current stock pricing and future profitability expectations. The price-to-book ratio is 17.22, indicating that the market values the company's equity at a significant premium of over 17 times its book value, likely due to the intangible value of its data repository and intellectual property. Alternative valuation measures such as a price-to-sales ratio of 6.70 and an EV/EBITDA of -52.85 further suggest that investors are pricing the stock based on revenue growth potential rather than current earnings power. The stock has traded between a 52-week low of $36.22 and a 52-week high of $104.32, meaning the current price sits within this historical volatility range but trades at a substantial discount relative to the recent peak. The beta value is N/A, so the specific volatility relative to the broader market cannot be quantified by this metric alone, though the wide 52-week range itself demonstrates significant price swings.

Growth & Income

Revenue growth year-over-year is robust at 83.0%, while earnings growth is N/A due to the company's current unprofitability, indicating that revenue expansion is outpacing earnings generation in the traditional sense. The company does not pay dividends, evidenced by a dividend yield of N/A and a payout ratio of 0.0%, meaning all available cash is reinvested into business operations and technology development rather than distributed to shareholders. This reinvestment strategy is typical for companies prioritizing market share expansion and platform scalability over immediate income generation for investors. Overall, Tempus AI, Inc. presents a profile of aggressive top-line growth funded by existing cash reserves and debt, with no current income component, reflecting a long-term investment thesis centered on future profitability rather than current cash flow returns.